These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35920104)

  • 1. Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis.
    Yuan W; Yang M; Zhu Y
    Bone Joint Res; 2022 Aug; 11(8):548-560. PubMed ID: 35920104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and validation of biomarkers of immune cell-related genes in postmenopausal osteoporosis: An observational study.
    Chen L; Zhao Y; Qiu J; Lin X
    Medicine (Baltimore); 2024 May; 103(19):e38042. PubMed ID: 38728482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
    Dong Q; Han Z; Tian L
    Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a potential diagnostic signature for postmenopausal osteoporosis
    Zeng R; Ke TC; Ou MT; Duan LL; Li Y; Chen ZJ; Xing ZB; Fu XC; Huang CY; Wang J
    Front Pharmacol; 2022; 13():944735. PubMed ID: 36105211
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
    Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
    Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying potential ferroptosis key genes for diagnosis and treatment of postmenopausal osteoporosis through competitive endogenous RNA network analysis.
    Huang C; Li Y; Li B; Liu X; Luo D; Liu Y; Wei M; Yang Z; Xu Y
    Heliyon; 2024 Jan; 10(1):e23672. PubMed ID: 38226266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of gene biomarkers in patients with postmenopausal osteoporosis.
    Yang C; Ren J; Li B; Jin C; Ma C; Cheng C; Sun Y; Shi X
    Mol Med Rep; 2019 Feb; 19(2):1065-1073. PubMed ID: 30569177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ROCK1 as a novel biomarker for postmenopausal osteoporosis and pan-cancer analysis.
    Lai B; Jiang H; Gao Y; Zhou X
    Aging (Albany NY); 2023 Sep; 15(17):8873-8907. PubMed ID: 37683138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment.
    Gong R; Ren S; Chen M; Wang Y; Zhang G; Shi L; Zhang C; Su R; Li Y
    Biomed Res Int; 2019; 2019():1907906. PubMed ID: 30809532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a potential signature to predict the risk of postmenopausal osteoporosis.
    Geng Y; Shao R; Xu T; Zhang L
    Gene; 2024 Feb; 894():147942. PubMed ID: 37935322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated single-cell and bulk RNA sequencing analysis reveal immune-related biomarkers in postmenopausal osteoporosis.
    Fang S; Ni H; Zhang Q; Dai J; He S; Min J; Zhang W; Li H
    Heliyon; 2024 Sep; 10(18):e38022. PubMed ID: 39328516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis.
    Hu Y; Han J; Ding S; Liu S; Wang H
    Front Endocrinol (Lausanne); 2022; 13():986384. PubMed ID: 36105394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feature selection approaches identify potential plasma metabolites in postmenopausal osteoporosis patients.
    Wang J; Wang Y; Zeng Y; Huang D
    Metabolomics; 2022 Nov; 18(11):86. PubMed ID: 36318345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning.
    Huang X; Ma J; Wei Y; Chen H; Chu W
    Front Genet; 2023; 14():1198417. PubMed ID: 37465165
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential diagnostic value of PD-1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients.
    Cai XP; Zhao Q; Guo ZD; Lin SJ; Chen ZX; Chen MY; Zheng L; Zhao KW
    J Clin Lab Anal; 2020 Jun; 34(6):e23223. PubMed ID: 32065479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis.
    Fei Q; Bai X; Lin J; Meng H; Yang Y; Guo A
    Int J Mol Med; 2018 Jun; 41(6):3537-3550. PubMed ID: 29568943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jiangu granules ameliorate postmenopausal osteoporosis via rectifying bone homeostasis imbalance: A network pharmacology analysis based on multi-omics validation.
    Li C; Lin X; Lin Q; Lin Y; Lin H
    Phytomedicine; 2024 Jan; 122():155137. PubMed ID: 37856991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis.
    Yang W; He Q; Hu Z; Xie X
    Int J Gen Med; 2022; 15():749-762. PubMed ID: 35082523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Subtypes and CD4
    Ning ZK; Hu CG; Huang C; Liu J; Zhou TC; Zong Z
    Front Oncol; 2020; 10():626912. PubMed ID: 33816214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis.
    Zhao K; Zhao Q; Guo Z; Chen Z; Hu Y; Su J; Chen L; He Z; Cai X; Chen M; Zheng L; Wang W; Wang Q
    Cell Physiol Biochem; 2018; 46(6):2508-2516. PubMed ID: 29742503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.